<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang H</submitter><funding>National Key Research and Development Program</funding><funding>National Natural Science Foundation of China</funding><pagination>20519</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11371808</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>We aimed to investigate the preventive effect of vitamin D2 on COVID-19 and the improvement of symptoms after COVID-19 infection. The study recruited 228 health care workers who tested negative PCR or antigen for COVID-19. Subjects were randomly allocated to vitamin D2 or non-intervention at a ratio 1:1. Subjects recorded PCR or antigen tests and the symptoms of COVID-19 twice a week during the follow-up visit. The concentration of serum 25-hydroxyvitamin D (25(OH)D), C-reaction protein (CRP), complement component C1q and inflammatory cytokines were measured. The rates of COVID-19 infection were 50.5% in the vitamin D2 group and 52.4% in the non-intervention group (P = 0.785). There was no difference in the COVID-19 symptoms between the two groups. The mean 25(OH)D level significantly incr</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Randomized trial of influence of vitamin D on the prevention and improvement of symptomatic COVID-19.</pubmed_title><pmcid>PMC11371808</pmcid><funding_grant_id>2020YFC2009004</funding_grant_id><funding_grant_id>82272554</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Tao L</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Cui L</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Liu N</pubmed_authors><pubmed_authors>Lv Y</pubmed_authors><pubmed_authors>Song C</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Wang T</pubmed_authors><pubmed_authors>Gao Y</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Xue L</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Liu D</pubmed_authors><pubmed_authors>Yuan W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Randomized trial of influence of vitamin D on the prevention and improvement of symptomatic COVID-19.</name><description>We aimed to investigate the preventive effect of vitamin D2 on COVID-19 and the improvement of symptoms after COVID-19 infection. The study recruited 228 health care workers who tested negative PCR or antigen for COVID-19. Subjects were randomly allocated to vitamin D2 or non-intervention at a ratio 1:1. Subjects recorded PCR or antigen tests and the symptoms of COVID-19 twice a week during the follow-up visit. The concentration of serum 25-hydroxyvitamin D (25(OH)D), C-reaction protein (CRP), complement component C1q and inflammatory cytokines were measured. The rates of COVID-19 infection were 50.5% in the vitamin D2 group and 52.4% in the non-intervention group (P = 0.785). There was no difference in the COVID-19 symptoms between the two groups. The mean 25(OH)D level significantly incr</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-07-15T10:59:26.916Z</modification><creation>2024-11-21T06:53:20.588Z</creation></dates><accession>S-EPMC11371808</accession><cross_references><pubmed>39227626</pubmed><doi>10.1038/s41598-024-66267-8</doi></cross_references></HashMap>